NSE / BSEHealthcare
β‚Ή369.30-3.85-1.03%
P/E21.4Mkt Capβ‚Ή3.74 K CrEV/EBITDA17.5

Indraprastha Medical Corporation Lt

P/E21.4Mkt Capβ‚Ή3.74 K CrEV/EBITDA17.5
Company Profile

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 26 Aug 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–Ό 18.49% over 1Y
Monthly Returns

Historically, Apr has averaged the highest return (+17.5%); Feb the lowest (-8.0%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-18.8%Negative MonthJan 2026: -18.85%+10.6%Positive MonthFeb 2026: +10.58%-7.5%Negative MonthMar 2026: -7.50%+8.4%Positive MonthApr 2026: +8.38%-10.8%Negative MonthMay 2026: -10.84%+7.8%Positive MonthJun 2026: +7.77%-5.4%Negative MonthJul 2026: -5.41%+0.9%*Neutral MonthAug 2026: +0.87%β€”β€”β€”β€”
2025-12.9%Negative MonthJan 2025: -12.87%-21.5%Negative MonthFeb 2025: -21.52%+8.0%Positive MonthMar 2025: +7.97%+2.7%Positive MonthApr 2025: +2.68%+11.2%Positive MonthMay 2025: +11.24%+10.2%Positive MonthJun 2025: +10.21%-3.2%Negative MonthJul 2025: -3.22%-6.7%Negative MonthAug 2025: -6.74%+1.5%Neutral MonthSep 2025: +1.46%+35.7%Positive MonthOct 2025: +35.71%-15.3%Negative MonthNov 2025: -15.29%-12.5%Negative MonthDec 2025: -12.47%
2024+9.0%Positive MonthJan 2024: +9.05%-4.6%Negative MonthFeb 2024: -4.64%-4.5%Negative MonthMar 2024: -4.50%+55.6%Positive MonthApr 2024: +55.60%-8.0%Negative MonthMay 2024: -7.97%-3.0%Negative MonthJun 2024: -3.03%+11.9%Positive MonthJul 2024: +11.91%+48.2%Positive MonthAug 2024: +48.22%+7.9%Positive MonthSep 2024: +7.92%-4.5%Negative MonthOct 2024: -4.51%+13.2%Positive MonthNov 2024: +13.20%+13.3%Positive MonthDec 2024: +13.30%
2023+5.1%Positive MonthJan 2023: +5.15%-9.2%Negative MonthFeb 2023: -9.15%-1.5%Neutral MonthMar 2023: -1.48%+8.0%Positive MonthApr 2023: +8.03%+5.8%Positive MonthMay 2023: +5.85%+2.2%Positive MonthJun 2023: +2.22%+33.1%Positive MonthJul 2023: +33.13%+49.3%Positive MonthAug 2023: +49.32%-7.3%Negative MonthSep 2023: -7.28%-1.0%Neutral MonthOct 2023: -1.05%+27.4%Positive MonthNov 2023: +27.43%-18.1%Negative MonthDec 2023: -18.09%
2022+2.3%Positive MonthJan 2022: +2.30%-15.3%Negative MonthFeb 2022: -15.28%-11.4%Negative MonthMar 2022: -11.44%+12.7%Positive MonthApr 2022: +12.66%-8.8%Negative MonthMay 2022: -8.81%-8.2%Negative MonthJun 2022: -8.16%+6.8%Positive MonthJul 2022: +6.80%+18.5%Positive MonthAug 2022: +18.51%-9.4%Negative MonthSep 2022: -9.38%+12.0%Positive MonthOct 2022: +12.02%+17.3%Positive MonthNov 2022: +17.29%-0.6%Neutral MonthDec 2022: -0.60%
2021β€”β€”β€”β€”β€”-2.7%Negative MonthJun 2021: -2.66%-1.8%Neutral MonthJul 2021: -1.84%-7.3%Negative MonthAug 2021: -7.26%+2.6%Positive MonthSep 2021: +2.61%-7.5%Negative MonthOct 2021: -7.50%+5.7%Positive MonthNov 2021: +5.70%-1.0%Neutral MonthDec 2021: -0.98%
AvgΒ±SD-3.0%Β±10.8%-8.0%Β±10.9%-3.4%Β±6.6%+17.5%Β±19.3%-2.1%Β±8.9%+1.1%Β±6.4%+6.9%Β±13.2%+17.2%Β±23.9%-0.9%Β±6.5%+6.9%Β±15.9%+9.7%Β±14.3%-3.8%Β±10.9%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 0.825x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή1.36 K Crβ–² 8.9%
EBITDA Growthβ€”
Net Profitβ‚Ή161.00 Crβ–² 29.8%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 100.0%
Revenue CAGR 5Y8.4%
EBITDA CAGR 5Y19.4%
Net Profit CAGR 5Y23.0%
NP Growth 1Y29.8%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή1.36 K Crβ€”β‚Ή161.00 Crβ€”β€”27.0%8.9%29.8%
Mar 2024β‚Ή1.25 K Crβ€”β‚Ή124.00 Crβ€”β€”25.9%13.3%44.2%
Mar 2023β‚Ή1.10 K Crβ€”β‚Ή86.00 Crβ€”β€”22.6%23.8%45.8%
Mar 2022β‚Ή888.00 Crβ€”β‚Ή59.00 Crβ€”β€”18.1%44.9%2850.0%
Mar 2021β‚Ή613.00 Crβ€”β‚Ή2.00 Crβ€”β€”0.7%-26.2%-95.5%
Mar 2020β‚Ή831.00 Crβ€”β‚Ή44.00 Crβ€”β€”16.4%5.5%57.1%
Mar 2019β‚Ή788.00 Crβ€”β‚Ή28.00 Crβ€”β€”11.5%4.6%33.3%
Mar 2018β‚Ή753.00 Crβ€”β‚Ή21.00 Crβ€”β€”9.0%-1.7%-19.2%
Mar 2017β‚Ή766.00 Crβ€”β‚Ή26.00 Crβ€”β€”11.3%1.5%8.3%
Mar 2016β‚Ή755.00 Crβ€”β‚Ή24.00 Crβ€”β€”10.7%5.7%-25.0%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales6787147557667537888316138881,0991,2451,3561,405
Total Expenses5876306756866787067435727689471,0501,1121,147
EBIT / Operating Profit9185807974828741120152195245258
OPM %13%12%11%10%10%10%11%7%14%14%16%18%18%
Other Income1110-1-100-39162226
Finance Costs10878976334466
Depreciation & Amortisation28283531313033333539404443
Profit Before Tax54503941344548479117166216234
Tax %35%34%37%36%38%36%9%46%26%26%25%26%-
Net Profit / PAT3532242621284425986124161175
EPS (β‚Ή)3.873.542.662.862.303.104.760.256.399.4013.5217.5619.06
Dividend Payout %47%51%68%63%65%52%0%0%39%32%33%26%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Indraprastha Medical Corporation Ltthis co.β‚Ή3.74 K Crβ‚Ή1.36 K Cr21.405.6817.548.9%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Indraprastha Medical Corporation Lt and the metrics that matter.

Browse the full Equiscale Academy